The presentation will be audio webcast live and available for replay fromDendreon's website, http://www.dendreon.com.
Advertisement
Dendreon Corporation is a biotechnology company whose mission is to targetcancer and transform lives through the discovery, development andcommercialization of novel therapeutics that harness the immune system tofight cancer. The Company applies its expertise in antigen identification,engineering and cell processing to produce active cellular immunotherapyproduct candidates designed to stimulate an immune response. Active cellularimmunotherapy holds promise because it may provide patients with a meaningfulclinical benefit, such as survival, combined with low toxicity. The Companyhas its headquarters in Seattle, Washington and is traded on the Nasdaq GlobalMarket under the symbol DNDN. For more information about the Company and itsprograms, visit http://www.dendreon.com.UBS Global Life Sciences Conference Grand Hyatt New York Thursday, September 27, 2007 9:00 a.m. ET
SOURCE Dendreon Corporation
